Morning Briefing
Summaries of health policy coverage from major news organizations
Most People Haven't Heard Of Trump's Drug Plan, But The Ones Who Have Aren't Optimistic It Will Lower Prices
Politico: Americans Skeptical Of Trump’s Drug Plan — If They’ve Even Heard Of It
President Donald Trump was hoping for a big win with voters when he rolled out a massive blueprint to lower drug prices in May. But two months later, most Americans haven’t even heard about it, a new poll shows. And few of the Americans who are aware of his plan believe it will lower drug prices. (Karlin-Smith and Ehley, 7/23)
The Hill: Poll: Majority Think Trump's Drug Plan Won't Lower Prices They Pay
Just 27 percent of adults said they had heard or read about Trump’s drug pricing plan, though, the poll finds. Key elements of the plan received favorable ratings in the poll, such as requiring TV ads for drugs to disclose the drug's price, which 63 percent of adults said they favor. The administration last week tried to step up its efforts on the drug pricing plan in the face of media coverage that has questioned how much of a difference it will actually make. (Sullivan, 7/23)
